- Home
- IKT vs SDST Comparison
IKT vs SDST Comparison
Compare IKT & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- SDST
- Stock Information
- Founded
- IKT 2008
- SDST 2022
- Country
- IKT United States
- SDST United States
- Employees
- IKT N/A
- SDST N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- SDST Blank Checks
- Sector
- IKT Health Care
- SDST Finance
- Exchange
- IKT Nasdaq
- SDST Nasdaq
- Market Cap
- IKT 167.2M
- SDST 176.9M
- IPO Year
- IKT 2020
- SDST N/A
- Fundamental
- Price
- IKT $2.20
- SDST $0.60
- Analyst Decision
- IKT Buy
- SDST Strong Buy
- Analyst Count
- IKT 2
- SDST 2
- Target Price
- IKT $8.00
- SDST $7.38
- AVG Volume (30 Days)
- IKT 167.2K
- SDST 428.7K
- Earning Date
- IKT 03-26-2025
- SDST 03-18-2025
- Dividend Yield
- IKT N/A
- SDST N/A
- EPS Growth
- IKT N/A
- SDST N/A
- EPS
- IKT N/A
- SDST N/A
- Revenue
- IKT $1.00
- SDST N/A
- Revenue This Year
- IKT N/A
- SDST N/A
- Revenue Next Year
- IKT N/A
- SDST N/A
- P/E Ratio
- IKT N/A
- SDST N/A
- Revenue Growth
- IKT N/A
- SDST N/A
- 52 Week Low
- IKT $1.12
- SDST $0.53
- 52 Week High
- IKT $4.20
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- IKT 45.02
- SDST N/A
- Support Level
- IKT $1.91
- SDST N/A
- Resistance Level
- IKT $2.22
- SDST N/A
- Average True Range (ATR)
- IKT 0.25
- SDST 0.00
- MACD
- IKT -0.01
- SDST 0.00
- Stochastic Oscillator
- IKT 29.59
- SDST 0.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is a development stage manufacturer of battery-grade lithium products deigned to supply the EV industry and helping to secure America's leadership in the energy transition. They enjoy a diversified supply of lithium from American brine sources.